HomeHealth NewsDr. V Mohan wins Harold Rifkin Award

Dr. V Mohan wins Harold Rifkin Award

First Indian to be conferred with the Award

Orlando, USA: Dr. V. Mohan, Chairman and Chief of Diabetology at Dr. Mohan’s Diabetes Specialities Centre and President & Chief of Diabetes Research of the Madras Diabetes Research Foundation has been conferred the prestigious “Harold Rifkin Distinguished International Service” in the cause of Diabetes Award by the American Diabetes Association (ADA). Dr. Mohan is the first Indian doctor to be conferred with this award by the American Diabetes Association ( ADA ).The award is dedicated in the memory of Dr. Harold Rifkin, an internationally recognized clinician, researcher and educator in diabetes.  It is one of the highest scientific achievement awards of American Diabetes Association given annually to an individual whose efforts have increased the awareness of the burden of diabetes worldwide to improve the care and lives of those with diabetes. The award recognizes Dr. Mohan’s outstanding service to the cause of diabetes in India and his pioneering work in the field of diabetes. 
The award was conferred on Dr. Mohan during the 78th Scientific Sessions of the American Diabetes Association at Orlando during the National Scientific Achievement Awards Presentation Ceremony. Supported by a grant from the Rifkin Family, this award honours individuals who have demonstrated outstanding research, education, and care in diabetes performed from an international perspective with an international project. 

READ ALSO : Absent without permission: 56 doctors issued show-cause notice in Kerala

Internationally renowned, Dr. Mohan has worked tirelessly to address the challenges of diabetes in India and developing countries. He has actively been involved in government health policy and advocacy programs related to diabetes, and he has served as President of the Research Society for the Study of Diabetes in India. Dr. Mohan’s comprehensive diabetes center boasts 41 branches with computerized clinical data on more than 4,21,000 patients.